. For quality control of HTM, a unique ampicillinand tetracycline-resistant, ,B-lactamase-negative strain of H. influenzae (ATCC 49247) was selected with the intention of providing on-scale MIC endpoints with commercial broth microdilution panels (2). However, more recently, some laboratories and commercial medium manufacturers began to experience difficulties with certain cephalosporins whose MICs or disk diffusion zone sizes were outside the accepted NCCLS control ranges (1; unpublished data presented to the NCCLS). Variations in the performance of some HTM broth and agar preparations were noted primarily with cefaclor, cefamandole, cefonicid, and cefuroxime (1). The MICs of these antibiotics were sometimes higher than the accepted ranges, and the zone sizes were smaller than the accepted NCCLS limits. Determinations with other antimicrobial agents, including other cephalosporins, either were not affected or were affected only modestly. These trends were not rejected categorically as indicative of inadequate media, because limited experiments demonstrated that such medium formulations might actually provide more sensitive * Corresponding author. detection of ampicillin-resistant, beta-lactamase-negative strains of H. influenzae (unpublished data presented to the NCCLS). Such strains have been reported previously as difficult to detect with HTM or other test media (8, 10) .
Inconsistent quality control results in disk diffusion testing of cefaclor, cefamandole, cefonicid, and cefuroxime with Haemophilus influenzae ATCC 49247 and Haemophilus test medium (HTM) prompted a search for an alternative control strain that would provide more reliable results. A five-laboratory study was conducted to evaluate two candidate H. influenzae strains as possible alternatives to the aforementioned strain. Repetitive testing of the candidate strains and H. influenzae ATCC 49247 over several days with a total of six different lots of HTM documented consistent performance of the two candidate strains and confirmed inconsistent results for some of the antibiotics with H. influenzae ATCC 49247. In particular, certain lots of HTM failed to yield cefaclor and cefamandole zone sizes within the quality control range advocated by the National Committee for Clinical Laboratory Standards. Because of the greater consistency offered by the new strains, one was selected (now designated H. influenzae ATCC 49766) to be recommended for routine quality control testing of cefaclor, cefamandole, cefonicid, cefuroxime, and the related carbacephem loracarbef. The new control strain and zone size ranges proposed here have been approved by the National Committee for Clinical Laboratory Standards in place of the previously recommended strain and zone size limits for testing of these five cephem antibiotics.
In 1987, a new medium for antimicrobial susceptibility testing of Haemophilus influenzae by either broth or agar dilution or disk diffusion methods was described (6) . Shortly thereafter, Haemophilus test medium (HTM) was endorsed by the National Committee for Clinical Laboratory Standards (NCCLS) for routine testing of Haemophilus species (11, 12) . For quality control of HTM, a unique ampicillinand tetracycline-resistant, ,B-lactamase-negative strain of H. influenzae (ATCC 49247) was selected with the intention of providing on-scale MIC endpoints with commercial broth microdilution panels (2) . However, more recently, some laboratories and commercial medium manufacturers began to experience difficulties with certain cephalosporins whose MICs or disk diffusion zone sizes were outside the accepted NCCLS control ranges (1; unpublished data presented to the NCCLS). Variations in the performance of some HTM broth and agar preparations were noted primarily with cefaclor, cefamandole, cefonicid, and cefuroxime (1) The results of this study confirmed that compliance is not achieved with the previous NCCLS quality control values (14) for the disk diffusion test with four cephalosporin antibiotics and some lots of HTM. The previously recommended H. influenzae control strain (ATCC 49247) is unique in that it is resistant to ampicillin by a non-,B-lactamasemediated mechanism, i.e., altered penicillin-binding proteins (9) . It appears from the results of this study that some lots of Mueller-Hinton agar used to prepare HTM affect the expression of cephem resistance in this strain. In previous studies (4, 5), Mueller-Hinton agar lots were shown to differ in the expression of resistance to methicillin in Staphylococcus aureus, another organism with 13-lactam resistance due to altered or low-affinity penicillin-binding proteins. Thus, it could be reasoned that enhanced expression of cephem resistance in H. influenzae ATCC 49247 when tested with certain HTM preparations is not necessarily unfavorable (1). In fact, such media might enhance the recognition of like strains, which have been notoriously difficult to detect in prior studies (8, 10) .
Since the purpose of quality control testing as outlined in the NCCLS guidelines (13) is to ensure precision in the determination of MICs or the development of inhibition zones, control strains that provide reproducible results when the medium and reagent elements of the susceptibility tests are performing satisfactorily should be selected. On that basis, it seems evident that H. influenzae ATCC 49766 is more suitable than H. influenzae ATCC 49247 for routine quality control testing of HTM with cefaclor, cefamandole, cefonicid, cefuroxime, and loracarbef. This assertion was affirmed recently by the NCCLS when the use of H. influenzae ATCC 49766 for the above-mentioned antibiotics was advocated in the most recently published NCCLS suceptibility testing document (15) . 
